Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shogo Ohkoshi

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
World Journal of Gastrointestinal Pharmacology and Therapeutics|February 21, 2017
Regenerative medicine using dental pulp stem cells for liver diseasesShogo Ohkoshi, Hajime Hara, Haruka Hirono, et al.
World Journal of Hepatology|December 16, 2015
Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesisShogo Ohkoshi, Haruka Hirono, Kazuhiko Watanabe, et al.
World Journal of Clinical Cases|July 26, 2021
Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apneaHaruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, et al.
World Journal of Gastroenterology|June 29, 2016
Natural regression of fibrosis in chronic hepatitis BShogo Ohkoshi, Haruka Hirono, Kazuhiko Watanabe, et al.
The American Journal of Case Reports|June 1, 2018
A Case of Right-Sided Ulcerative Colitis with Mesalamine-Induced Hypersensitivity ReactionsHaruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, et al.
Case Reports in Gastroenterology|September 1, 2010
Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic InterventionShogo Ohkoshi, Satoshi Yamagiwa, Masahiko Yano, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2007
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell cultureMasahiko Yano, Masanori Ikeda, Ken-Ichi Abe, et al.
Digestive Diseases and Sciences|December 19, 2008
Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis CYasushi Tamura, Satoshi Yamagiwa, Yohei Aoki, et al.
Internal Medicine (Tokyo, Japan)|June 10, 2003
A patient with Takayasu's arteritis treated with corticosteroids who developed primary biliary cirrhosisSatoshi Ito, Shogo Ohkoshi, Tomoyoshi Aoyagi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 11, 2008
Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cellsSatoshi Yamagiwa, Yasunobu Matsuda, Takafumi Ichida, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
World Journal of Gastrointestinal Pharmacology and Therapeutics|February 21, 2017
Regenerative medicine using dental pulp stem cells for liver diseasesShogo Ohkoshi, Hajime Hara, Haruka Hirono, et al.
World Journal of Hepatology|December 16, 2015
Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesisShogo Ohkoshi, Haruka Hirono, Kazuhiko Watanabe, et al.
World Journal of Clinical Cases|July 26, 2021
Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apneaHaruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, et al.
World Journal of Gastroenterology|June 29, 2016
Natural regression of fibrosis in chronic hepatitis BShogo Ohkoshi, Haruka Hirono, Kazuhiko Watanabe, et al.
The American Journal of Case Reports|June 1, 2018
A Case of Right-Sided Ulcerative Colitis with Mesalamine-Induced Hypersensitivity ReactionsHaruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, et al.
Case Reports in Gastroenterology|September 1, 2010
Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic InterventionShogo Ohkoshi, Satoshi Yamagiwa, Masahiko Yano, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2007
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell cultureMasahiko Yano, Masanori Ikeda, Ken-Ichi Abe, et al.
Digestive Diseases and Sciences|December 19, 2008
Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis CYasushi Tamura, Satoshi Yamagiwa, Yohei Aoki, et al.
Internal Medicine (Tokyo, Japan)|June 10, 2003
A patient with Takayasu's arteritis treated with corticosteroids who developed primary biliary cirrhosisSatoshi Ito, Shogo Ohkoshi, Tomoyoshi Aoyagi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 11, 2008
Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cellsSatoshi Yamagiwa, Yasunobu Matsuda, Takafumi Ichida, et al.
Pageof 5